These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Pollinosis. II. Specific hyposensitization: indications and results of treatment. A study with the allergen preparation Stallergenes-Depot in the pollen season of 1976, 1977 and 1978].
    Author: Wüthrich B, Häfner G.
    Journal: Schweiz Med Wochenschr; 1980 Feb 23; 110(8):281-90. PubMed ID: 7367848.
    Abstract:
    The efficacy of hyposensitization treatment of pollen allergy has been proven by a series of double blind studies. The clinical success of specific treatment with semi-depot extracts amounts, according to retrospective studies, to 70% and 90% in hay fever and seasonal asthma. Our results, with a success quota averaging 75% obtained by 821 courses of treatment between 1976 and 1978, are within the range reported by other authors. Only 1-2% of the patients experienced a worsening of the allergic symptoms during immunotherapy. The success quota in connection with organ manifestation varied between 65.7% to 86.5% for asthma (up to 34% cured), 59,8% to 79% for rhinitis and 70,5% to 84% for conjuncitivitis. The global results of 409 hyposensitization treatments by outside practitioners in pollen season 1976 were not inferior statistically to those obtained by our allergy unit. The results after 2 and 3 courses, with a success quota of 85%, were statistically significantly better than after the first course. The local reactions observed in approximately 27% of patients, and the allergic generalized reactions seen in approximately 7% during hyposensitization, are described and discussed. Guidelines for the indication for hyposensitization treatment of pollinosis, for the composition of the pollen extracts (only a few relevant allergens!) and for practical performance are given.
    [Abstract] [Full Text] [Related] [New Search]